RANKINGS

POPULAR STOCKS

Johnson & Johnson

NYSE:JNJ

Location

United States

Market Cap

USD 377.99 B

Share Price

USD 155.22

Avg Daily Volume

9,317,871

Change (1 day)

-1.20%

Change (1 year)

6.65%

Change (YTD)

7.33%

Johnson & Johnson Price to Book Ratio (P/B) on June 16, 2025: 5.19

Johnson & Johnson Price to Book Ratio (P/B) is 5.19 on June 16, 2025, a 5.63% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Johnson & Johnson 52-week low Price to Book Ratio (P/B) is 5.74 on June 16, 2025, which is 10.65% above the current Price to Book Ratio (P/B).
  • Johnson & Johnson 52-week low Price to Book Ratio (P/B) is 4.88 on June 16, 2025, which is -6.03% below the current Price to Book Ratio (P/B).
  • Johnson & Johnson average Price to Book Ratio (P/B) for the last 52 weeks is 5.31.
Key data
Date Price to Book Ratio (P/B) Price to Sales Ratio (P/S) Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield
Market news
NYSE: JNJ

Johnson & Johnson

CEO Mr. Joaquin Duato
IPO Date Jan. 2, 1943
Location United States
Headquarters One Johnson & Johnson Plaza
Employees 138,100
Sector 🏥 Health Care
Industries
Pharmaceuticals
💄 Cosmetics
💊 Drugstores & Retail Pharmacies
🧴 Personal Care
🛍 Specialty Retail
Description

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Similar companies

GSK.L

GSK plc

USD 20.16

-1.65%

HLN.L

Haleon plc

USD 5.31

-1.21%

600436.SS

Zhangzhou Pientzehuang Pharmaceutical., Ltd

USD 27.97

-0.25%

000538.SZ

Yunnan Baiyao Group Co.,Ltd

USD 7.78

-1.09%

4164.SR

Nahdi Medical Company

USD 33.74

2.27%

AJANTPHARM.NS

Ajanta Pharma Limited

USD 30.21

0.00%

4527.T

Rohto Pharmaceutical Co.,Ltd.

USD 14.64

2.41%

4015.SR

Jamjoom Pharmaceuticals Factory Company

USD 43.16

2.25%

GXI.DE

Gerresheimer AG

USD 53.36

-1.25%

600572.SS

Zhejiang CONBA Pharmaceutical Co.,Ltd.

USD 0.63

-1.28%

LLY

Eli Lilly and Company

USD 807.58

-1.44%

ABBV

AbbVie Inc.

USD 190.86

-0.11%

RO.SW

Roche Holding AG

USD 343.54

-2.65%

AZN.L

AstraZeneca PLC

USD 146.80

-1.46%

MRK

Merck & Co., Inc.

USD 80.96

-0.92%

AMGN

Amgen Inc.

USD 295.56

0.11%

PFE

Pfizer Inc.

USD 24.40

-0.57%

GILD

Gilead Sciences, Inc.

USD 110.83

0.77%

SAN.PA

Sanofi

USD 99.27

-0.99%

BMY

Bristol-Myers Squibb Company

USD 48.66

-2.19%

MCK

McKesson Corporation

USD 719.57

-1.19%

ELV

Elevance Health Inc.

USD 376.53

-2.09%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 50.88

-1.30%

COR

Cencora, Inc.

USD 292.50

-1.03%

REGN

Regeneron Pharmaceuticals, Inc.

USD 522.68

-1.24%

LONN.SW

Lonza Group AG

USD 695.17

-0.81%

L.TO

Loblaw Companies Limited

USD 162.31

-0.78%

600276.SS

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.49

-0.21%

4502.T

Takeda Pharmaceutical Company Limited

USD 30.06

0.34%

RKT.L

Reckitt Benckiser Group plc

USD 69.01

-0.12%

SUNPHARMA.NS

Sun Pharmaceutical Industries Limited

USD 19.35

-1.25%

4568.T

Daiichi Sankyo Company, Limited

USD 23.88

-1.07%

UCB.BR

UCB SA

USD 187.20

-0.85%

4578.T

Otsuka Holdings Co., Ltd.

USD 50.03

0.42%

3692.HK

Hansoh Pharmaceutical Group Company Limited

USD 3.66

-1.84%

DIVISLAB.NS

Divi's Laboratories Limited

USD 77.71

-0.06%

TEVA.TA

Teva Pharmaceutical Industries Limited

USD 17.50

1.85%

INSM

Insmed Incorporated

USD 101.59

2.90%

6618.HK

JD Health International Inc.

USD 5.40

0.16%

WST

West Pharmaceutical Services, Inc.

USD 224.30

1.08%

SMMT

Summit Therapeutics Inc.

USD 19.95

0.86%

CIPLA.NS

Cipla Limited

USD 17.68

-0.41%

DRREDDY.NS

Dr. Reddy's Laboratories Limited

USD 15.64

-0.12%

UTHR

United Therapeutics Corporation

USD 288.56

1.84%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 38.31

0.59%

1093.HK

CSPC Pharmaceutical Group Limited

USD 1.06

-4.53%

1177.HK

Sino Biopharmaceutical Limited

USD 0.65

-3.37%

MANKIND.NS

Mankind Pharma Limited

USD 27.51

-0.17%

ZYDUSLIFE.NS

Zydus Lifesciences Limited

USD 11.28

-0.45%

BMRN

BioMarin Pharmaceutical Inc.

USD 56.24

0.04%

StockViz Staff

June 17, 2025

Any question? Send us an email